No Data
No Data
Kunbo Medical-B (2216.HK): Transformation breakthrough, resilient growth in the cold winter
In the capital winter, overseas medical instruments companies are facing unprecedented challenges.
Konbo Medical-B (02216) released its interim performance, with a shareholder attributable loss of 7.943 million US dollars, a decrease of 46.08% year-on-year.
Kangbo Medical-B (02216) released its interim performance for the six months ending June 30, 2024, and the group achieved...
Express News | Broncus Holding Corp H1 Gross Profit USD 3 Million
BRONCUS-B: ANNOUNCEMENT OF INTERIM RESULTSFOR THE SIX MONTHS ENDED JUNE 30, 2024
Kunbo Medical -B(02216.HK): The registered business address of its subsidiary, Hangzhou Kunbo Biotechnology, has been changed.
Guolonghui August 26th | Kunbo Medical-B (02216.HK) announced that the registered business address of the company's subsidiary and the main operating entity of the group in China, Hangzhou Kunbo Biological Technology Co., Ltd., has been changed to Room 1101-4, Building 1, No. 502 Linping Avenue, Economic and Technological Development Zone, Linping District, Hangzhou City, Zhejiang Province, China. This is the new main business location for the group in China.
Kangbo Medical-B (02216.HK) held a board of directors meeting on August 29 to consider and approve the interim performance.
On August 19th, Gelonhui reported that Komb Medical - B (02216.HK) announced that the board of directors meeting will be held on August 29, 2024 (Thursday) to consider and approve the unaudited interim performance of the company and its subsidiaries for the six months ending June 30, 2024.
No Data
102768097 : how to do?